|07/21/17||Leading Medical Physics Meeting to Feature First Presentations on Clinical Experience with ViewRay's MRIdian Linac|
|30 Presentations Highlight MRIdian's Growing Role in Cancer Care
CLEVELAND, July 21, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), makers of the world's only FDA-cleared MRI-guided radiation therapy system with linear accelerator-based delivery, announced today that the company's MRIdian® System is the focus of 30 abstracts selected by the American Association of Physicists in Medicine (AAPM) for presentation during their 2017 Annual Meeting. AAPM is the largest association of medical ph... |
|07/20/17||First Patients Treated with ViewRay's MRIdian Linac System at Henry Ford Health System|
|World's First FDA-Cleared MRI-guided Linear Accelerator-based Radiation Therapy System Now Treating Patients
CLEVELAND, July 20, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the first cancer patients have been treated using the company's MRIdian Linac system at Henry Ford Health System in Metro Detroit. MRIdian Linac is the world's only FDA-cleared MRI-guided radiation therapy system with linear accelerator-based delivery. MRIdian Linac is the company's second genera... |
|06/26/17||National Cancer Center Japan Treats First Patients Using ViewRay MRIdian System|
|Brings Advantages of MRI-Guided Radiation Therapy to Treatment of Lung, Liver and Pancreatic Cancer Patients
CLEVELAND, June 26, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the National Cancer Center (NCC) in Tokyo, Japan treated its first patients using ViewRay's MRIdian System, the world's first and only clinical MRI-guided radiation therapy system. Among the first indications treated at NCC were cancers of the lung, liver and pancreas.
The MRIdian System comb... |
|06/13/17||ViewRay® to Present at The JMP Securities Life Sciences Conference|
|CLEVELAND, June 13, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer is scheduled to present at The JMP Securities Life Sciences Conference in New York, NY.
The JMP Securities Life Sciences Conference
Tuesday, June 20
An audio webcast of the Company's presentation will be available on the investor relations sectio... |